Cell line · CVCL_3901
EA.hy 926
Hybrid cell line, Homo sapiens. 32 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. EA.hy 926. Cell lines, record CVCL_3901. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_3901
On this page
Cell line
As Cellosaurus gives it.
- Name
- EA.hy 926
- Accession
- CVCL_3901
- RRID
- RRID:CVCL_3901
- Synonyms
- EA. hy 926, EA hy 926, EA-hy926, EAhy 926, EAHY-926, EA.Hy926, EA.hy926, EAhy926, EaHy926, Eahy926
- Species
- Homo sapiens (Human)
- Category
- Hybrid cell line
- Parent
- A549/8 (CVCL_IY87)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers32
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| FKBP12 determines ligand-specific SMAD signaling in individual living endothelial cells. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TH1177, Clemastine, and Benzhydryl Derivatives Act as Novel Extracellular Blockers of ORAI Channels. | Biomolecules | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Tumor-Derived Exosomal TAGLN2 Promotes Metastasis by Inducing Vascular Permeability and Angiogenesis via the NRP1/SEMA4D/YAP Axis. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The potential effect of albumin replacement on immune modulation and sphingosine 1-phosphate dynamics. | Sci Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| DNA Nanoflower LYTACs Enable Efficient VEGF Degradation and Verteporfin Loading for Combined Therapy of Wet Age-Related Macular Degeneration. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Pathology-tailored nanotherapy via Galectin-3-targeted and triple-responsive nanoparticles enables multimodal therapy against aortic dissection. | J Nanobiotechnology | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Rational engineering of an antifreeze-based biomaterial with dual-enhanced ice-binding and delivery for high-efficiency cryopreservation. | J Adv Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Two-Step Air/Water Oxidation Process for the Long-Lasting Photoluminescence and Biological Viability (MTT Assay) of Porous Silicon Particles. | J Xenobiot | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Adaptation of mitochondrial bioenergetics to coenzyme Q deficiency in human endothelial cells after chronic exposure to bisphosphonates. | Sci Rep | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Annexin A5 controls VDAC1-dependent mitochondrial Ca2+ homeostasis and determines cellular susceptibility to apoptosis. | EMBO J | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 32
See all 32 papersRelatives7
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | A549/8 | CVCL_IY87 | Cell lines | |
| Derived from it | EA.hy926-EGFP | CVCL_C8WK | Cell lines | |
| Derived from it | EA.hy926-Luc | CVCL_C8VU | Cell lines | |
| Derived from it | HyCyte EA.hy 926 stable cell line for hCHST15 overexpression | CVCL_F4PJ | Cell lines | |
| Derived from it | HyCyte EA.hy 926 stable cell line for hHIF1A overexpression | CVCL_F4P1 | Cell lines | |
| Derived from it | HyCyte EA.hy 926 stable cell line for hIL6R overexpression | CVCL_F4TH | Cell lines | |
| Derived from it | HyCyte EA.hy 926 stable cell line for mPDK1 overexpression | CVCL_F4NG | Cell lines |
Cell banks7
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ABM | T0735 | ABM | |
| ATCC | CRL-2922 | ATCC | |
| BCRJ | 0345 | BCRJ | |
| CLS | 305034 | CLS | |
| KCB | KCB 2014048YJ | Cellosaurus | |
| NCBI_Iran | C641 | Cellosaurus | |
| Ubigene | YC-C032 | Ubigene |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_3901
GET https://conductscience.org/api/cell-lines/v1/CVCL_3901/papers?page=2